GOVX MEXC RealStocks
Own real GOVX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 02:28:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
GeoVax Labs, Inc. New (GOVX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.00, with a market capitalization of $1.10M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.51 to $270.66. This page covers its latest market performance, valuation, price trends and company information.
$1.10M | |
$1.94 | |
$2.43 | |
$1.67 | |
$2.01 | |
241.42K | |
154.51K | |
-- | |
$270.66 | |
$1.51 | |
-- | |
2026-06-30 |
GeoVax Labs, Inc. New (GOVX) last closed at $2.00 as of 2026-11-19 00:58:00, up 17.41% ($0.35) from the previous close of $2.01.
During the latest regular trading session, GOVX traded between $1.67 and $2.43, with a volume of 241.42K shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, GeoVax Labs, Inc. New (GOVX) moved from $3.43 to $2.00, representing a decline of 41.70% ($1.43).
The stock traded between $1.51 and $4.04 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.16 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.2%
GOVX is currently trading at $2.00, placing it 0.2% of the way from its 52-week low of $1.51 to its 52-week high of $270.66. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 19 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for GeoVax Labs, Inc. New.
Stock Split | |
|---|---|
| Split Date | Nov 11, 2026 |
| Split Ratio | 1-for-24 |
Eligible investors can buy real shares of GeoVax Labs, Inc. New (GOVX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to GOVX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between GOVX shares and USD.
GOVX Shares to USD
1.00 GOVX shares = 2.001 USD
Calculations are estimates based on the latest available price and are for reference only.